KYAN Therapeutics Company
KYAN Therapeutics is a clinical-stage AI company leveraging its proprietary technology platforms to transform the way patients are treated.
Technology:
Artificial Intelligence, Biopharma, Biotechnology, Health Care, Life Science, Pharmaceutical, Therapeutics
Industry:
AI, End-to-end Drug Development
Headquarters:
Singapore, Central Region, Singapore
Founded Date:
2014-06-10
Employees Number:
1-10
Funding Status:
Seed
Investors Number:
3
Total Funding:
5000000
Estimated Revenue:
Less than $1M
Last Funding Date:
2022-10-26
Last Funding Type:
Seed
Register and Claim Ownership